logo

COLL

CollegiumยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

COLL Profile

Collegium Pharmaceutical, Inc.

A leading specialty pharmaceutical company that develops generic and branded drugs primarily for the treatmet of chronic pain and other diseases

Pharmaceutical
--
05/07/2015
NASDAQ Stock Exchange
357
12-31
Common stock
100 Technology Center Drive, Stoughton, MA 02072
--
Collegium Pharmaceutical, Inc., was incorporated in Delaware in April 2002 and subsequently re-incorporated in Virginia in July 2014. The company's mission is to build a leading and diversified specialty pharmaceutical company dedicated to improving the lives of critically ill patients. The company has leveraged R&D efforts and acquisition and licensing relationships with third parties to develop a meaningful range of differentiated products for the treatment of moderate to severe pain.